Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Pharmaceuticals Corp (NY: ZOM )

0.2200 +0.0122 (+5.87%)
Official Closing Price Updated: 8:00 PM EDT, Jul 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 41,582,224
Open 0.2089
Bid (Size) 0.2500 (66)
Ask (Size) 0.2519 (1)
Prev. Close 0.2078
Today's Range 0.2030 - 0.2240
52wk Range 0.1750 - 0.8091
Shares Outstanding 979,899,668
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian Team
ANN ARBOR, MI / ACCESSWIRE / June 28, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for equine and... 
From Zomedica Corp.
Via AccessWire
Topics Supply Chain
Exposures Supply Chain
Zomedica to Participate in Panel Discussion at Animal Health Investment Forum
ANN ARBOR, MI / ACCESSWIRE / June 21, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire

Performance

YTD
-38.39%
-38.39%
1 Month
-14.03%
-14.03%
3 Month
-35.24%
-35.24%
6 Month
-38.39%
-38.39%
1 Year
-71.79%
-71.79%

More News

Read More
Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared
From Zomedica Corp.
Via AccessWire
Dogs Win, Investors Lose With Zomedica
Via InvestorPlace
It’s Going to Take a Lot to Get Zomedica Stock Out of the Doghouse
Via InvestorPlace
Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses
From Zomedica Corp.
Via AccessWire
Topics Law Enforcement
Exposures Legal
Zomedica to Present at JMP Securities Life Sciences Conference
From Zomedica Corp.
Via AccessWire
Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate Secretary
From Zomedica Corp.
Via AccessWire
Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line
From Zomedica Corp.
Via AccessWire
Traders News Source Interviews Larry Heaton, CEO of Zomedica Corp.
From Traders News Source
Via AccessWire
Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans
From Zomedica Corp.
Via AccessWire
Why Zomedica Shares Are Falling Today
Via Benzinga
Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up 38% from 2021 Combined Revenues
From Zomedica Corp.
Via AccessWire
Earnings Scheduled For May 10, 2022
Via Benzinga
Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners' Sponsorship
From Zomedica Corp.
Via AccessWire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Continue to Steer Clear of MULN Stock
Via InvestorPlace
Zomedica to Present at H.C. Wainwright Global Investment Conference
From Zomedica Corp.
Via AccessWire
Zomedica's Announces Designation of Pulsevet System as the Official Shock Wave Therapy of the American Quarter Horse Association
From Zomedica Corp.
Via AccessWire
Zomedica Announces Launch of eACTH Assay for Truforma(R) Platform
From Zomedica Corp.
Via AccessWire
Zomedica (NYSE American: ZOM) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
Via Investor Brand Network
Zomedica (NYSE American: ZOM) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
Via CryptoCurrencyWire
Will the PulseVet Acquisition Continue to Deliver Sales for Zomedica?
Via InvestorPlace
Zomedica Corporation Reports 2021 Fourth Quarter & Full Year Results
From Zomedica Corp.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.